Transient iatrogenic immunodeficiency-related B-cell lymphoproliferative disorder of the skin in a patient with mycosis fungoides/Sézary syndrome
- 18 January 2011
- journal article
- case report
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 38 (3) , 295-297
Abstract
Immunodeficiency-related lymphoproliferative disorders (IR-LPD) may occur in the setting of immunosuppressive therapy with methotrexate and TNF-α antagonists. As far as we are aware, this is the first report of an Epstein-Barr virus-associated B-cell lymphoproliferative disorder, secondary to methotrexate therapy in a patient with mycosis fungoides/Sézary syndrome.Keywords
This publication has 4 references indexed in Scilit:
- Epstein-Barr Virus in Cutaneous T-Cell Lymphomas: Evaluation of the Viral Presence and Significance in Skin and Peripheral BloodJournal of Investigative Dermatology, 2009
- CD25 Expression Is Correlated with Histological Grade and Response to Denileukin Diftitox in Cutaneous T-Cell LymphomaJournal of Investigative Dermatology, 2006
- Expression of Epstein-Barr virus in cutaneous T-cell lymphoma including mycosis fungoidesInternational Journal of Cancer, 2001
- Quantitation of intraepidermal T‐cell subsets in formalin‐fixed, paraffin‐embedded tissue helps in the diagnosis of mycosis fungoidesJournal of Cutaneous Pathology, 1999